Global Viral Vector CDMO Services Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Viral Vector CDMO Services market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
Viral Vector CDMO Services refers to contract development and manufacturing organizations (CDMOs) that provide custom production and development services for viral vectors. Viral vectors are a commonly used gene therapy tool that deliver target genes into human cells to treat disease. Viral Vector CDMO Services provides various types of viral vector production services, including adenovirus vectors, AAV vectors, and LV vectors.
CDMO companies usually provide a full range of viral vector production and development services from the research stage to commercial production, including quality control, preparation, analysis, packaging and storage services. These services help accelerate the development and commercialization of gene therapy drugs and advance the field of gene therapy.
CDMO companies can also help customers develop production plans that suit their product needs, and provide customized technical support and solutions based on customer needs. Customers can choose the appropriate CDMO company as a partner based on their needs to ensure the high-quality production and successful launch of their gene therapy products.
The Global Info Research report includes an overview of the development of the Viral Vector CDMO Services industry chain, the market status of Vaccine Development (AAV, Lentivirus), Gene Therapy (AAV, Lentivirus), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Viral Vector CDMO Services.
Regionally, the report analyzes the Viral Vector CDMO Services markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Viral Vector CDMO Services market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Viral Vector CDMO Services market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Viral Vector CDMO Services industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., AAV, Lentivirus).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Viral Vector CDMO Services market.
Regional Analysis: The report involves examining the Viral Vector CDMO Services market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Viral Vector CDMO Services market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Viral Vector CDMO Services:
Company Analysis: Report covers individual Viral Vector CDMO Services players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Viral Vector CDMO Services This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Vaccine Development, Gene Therapy).
Technology Analysis: Report covers specific technologies relevant to Viral Vector CDMO Services. It assesses the current state, advancements, and potential future developments in Viral Vector CDMO Services areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Viral Vector CDMO Services market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Viral Vector CDMO Services market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Viral Vector CDMO Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Viral Vector CDMO Services, with revenue, gross margin and global market share of Viral Vector CDMO Services from 2018 to 2023.
Chapter 3, the Viral Vector CDMO Services competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Viral Vector CDMO Services market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Viral Vector CDMO Services.
Chapter 13, to describe Viral Vector CDMO Services research findings and conclusion.
Viral Vector CDMO Services refers to contract development and manufacturing organizations (CDMOs) that provide custom production and development services for viral vectors. Viral vectors are a commonly used gene therapy tool that deliver target genes into human cells to treat disease. Viral Vector CDMO Services provides various types of viral vector production services, including adenovirus vectors, AAV vectors, and LV vectors.
CDMO companies usually provide a full range of viral vector production and development services from the research stage to commercial production, including quality control, preparation, analysis, packaging and storage services. These services help accelerate the development and commercialization of gene therapy drugs and advance the field of gene therapy.
CDMO companies can also help customers develop production plans that suit their product needs, and provide customized technical support and solutions based on customer needs. Customers can choose the appropriate CDMO company as a partner based on their needs to ensure the high-quality production and successful launch of their gene therapy products.
The Global Info Research report includes an overview of the development of the Viral Vector CDMO Services industry chain, the market status of Vaccine Development (AAV, Lentivirus), Gene Therapy (AAV, Lentivirus), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Viral Vector CDMO Services.
Regionally, the report analyzes the Viral Vector CDMO Services markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Viral Vector CDMO Services market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Viral Vector CDMO Services market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Viral Vector CDMO Services industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., AAV, Lentivirus).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Viral Vector CDMO Services market.
Regional Analysis: The report involves examining the Viral Vector CDMO Services market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Viral Vector CDMO Services market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Viral Vector CDMO Services:
Company Analysis: Report covers individual Viral Vector CDMO Services players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Viral Vector CDMO Services This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Vaccine Development, Gene Therapy).
Technology Analysis: Report covers specific technologies relevant to Viral Vector CDMO Services. It assesses the current state, advancements, and potential future developments in Viral Vector CDMO Services areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Viral Vector CDMO Services market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Viral Vector CDMO Services market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- AAV
- Lentivirus
- Adenovirus
- HSV
- Others
- Vaccine Development
- Gene Therapy
- Academic Scientific Research Institution
- Others
- Thermo Fisher Scientific
- Lonza
- Catalent
- Charles River
- Merck
- SK pharmteco
- Oxford Biomedica
- AGC Biologics?MolMed?
- Gene Universal
- Polyplus (Sartorius)
- CCRM
- FUJIFILM Diosynth Biotechnologies
- Biovian
- Miltenyi Bioindustry
- Aldevron
- Takara Bio
- Yposkesi
- Genezen
- GenScript ProBio
- EurekaBio
- Obio Technology
- GeneSail Biotech
- VectorBuilder
- WuXi ATU
- Ubrigene
- Porton Biologics
- Pharmaron
- PackGene Biotechnology
- Hillgene
- Asymchem
- Exthera
- Flash Therapeutics
- VIVEBiotech
- FinVector
- uBriGene
- Eurogentec
- VGXI
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Viral Vector CDMO Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Viral Vector CDMO Services, with revenue, gross margin and global market share of Viral Vector CDMO Services from 2018 to 2023.
Chapter 3, the Viral Vector CDMO Services competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Viral Vector CDMO Services market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Viral Vector CDMO Services.
Chapter 13, to describe Viral Vector CDMO Services research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Viral Vector CDMO Services
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Viral Vector CDMO Services by Type
1.3.1 Overview: Global Viral Vector CDMO Services Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Viral Vector CDMO Services Consumption Value Market Share by Type in 2022
1.3.3 AAV
1.3.4 Lentivirus
1.3.5 Adenovirus
1.3.6 HSV
1.3.7 Others
1.4 Global Viral Vector CDMO Services Market by Application
1.4.1 Overview: Global Viral Vector CDMO Services Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Vaccine Development
1.4.3 Gene Therapy
1.4.4 Academic Scientific Research Institution
1.4.5 Others
1.5 Global Viral Vector CDMO Services Market Size & Forecast
1.6 Global Viral Vector CDMO Services Market Size and Forecast by Region
1.6.1 Global Viral Vector CDMO Services Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Viral Vector CDMO Services Market Size by Region, (2018-2029)
1.6.3 North America Viral Vector CDMO Services Market Size and Prospect (2018-2029)
1.6.4 Europe Viral Vector CDMO Services Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Viral Vector CDMO Services Market Size and Prospect (2018-2029)
1.6.6 South America Viral Vector CDMO Services Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Viral Vector CDMO Services Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Viral Vector CDMO Services Product and Solutions
2.1.4 Thermo Fisher Scientific Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.2 Lonza
2.2.1 Lonza Details
2.2.2 Lonza Major Business
2.2.3 Lonza Viral Vector CDMO Services Product and Solutions
2.2.4 Lonza Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Lonza Recent Developments and Future Plans
2.3 Catalent
2.3.1 Catalent Details
2.3.2 Catalent Major Business
2.3.3 Catalent Viral Vector CDMO Services Product and Solutions
2.3.4 Catalent Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Catalent Recent Developments and Future Plans
2.4 Charles River
2.4.1 Charles River Details
2.4.2 Charles River Major Business
2.4.3 Charles River Viral Vector CDMO Services Product and Solutions
2.4.4 Charles River Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Charles River Recent Developments and Future Plans
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business
2.5.3 Merck Viral Vector CDMO Services Product and Solutions
2.5.4 Merck Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Merck Recent Developments and Future Plans
2.6 SK pharmteco
2.6.1 SK pharmteco Details
2.6.2 SK pharmteco Major Business
2.6.3 SK pharmteco Viral Vector CDMO Services Product and Solutions
2.6.4 SK pharmteco Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 SK pharmteco Recent Developments and Future Plans
2.7 Oxford Biomedica
2.7.1 Oxford Biomedica Details
2.7.2 Oxford Biomedica Major Business
2.7.3 Oxford Biomedica Viral Vector CDMO Services Product and Solutions
2.7.4 Oxford Biomedica Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Oxford Biomedica Recent Developments and Future Plans
2.8 AGC Biologics?MolMed?
2.8.1 AGC Biologics?MolMed? Details
2.8.2 AGC Biologics?MolMed? Major Business
2.8.3 AGC Biologics?MolMed? Viral Vector CDMO Services Product and Solutions
2.8.4 AGC Biologics?MolMed? Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 AGC Biologics?MolMed? Recent Developments and Future Plans
2.9 Gene Universal
2.9.1 Gene Universal Details
2.9.2 Gene Universal Major Business
2.9.3 Gene Universal Viral Vector CDMO Services Product and Solutions
2.9.4 Gene Universal Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Gene Universal Recent Developments and Future Plans
2.10 Polyplus (Sartorius)
2.10.1 Polyplus (Sartorius) Details
2.10.2 Polyplus (Sartorius) Major Business
2.10.3 Polyplus (Sartorius) Viral Vector CDMO Services Product and Solutions
2.10.4 Polyplus (Sartorius) Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Polyplus (Sartorius) Recent Developments and Future Plans
2.11 CCRM
2.11.1 CCRM Details
2.11.2 CCRM Major Business
2.11.3 CCRM Viral Vector CDMO Services Product and Solutions
2.11.4 CCRM Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 CCRM Recent Developments and Future Plans
2.12 FUJIFILM Diosynth Biotechnologies
2.12.1 FUJIFILM Diosynth Biotechnologies Details
2.12.2 FUJIFILM Diosynth Biotechnologies Major Business
2.12.3 FUJIFILM Diosynth Biotechnologies Viral Vector CDMO Services Product and Solutions
2.12.4 FUJIFILM Diosynth Biotechnologies Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
2.13 Biovian
2.13.1 Biovian Details
2.13.2 Biovian Major Business
2.13.3 Biovian Viral Vector CDMO Services Product and Solutions
2.13.4 Biovian Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Biovian Recent Developments and Future Plans
2.14 Miltenyi Bioindustry
2.14.1 Miltenyi Bioindustry Details
2.14.2 Miltenyi Bioindustry Major Business
2.14.3 Miltenyi Bioindustry Viral Vector CDMO Services Product and Solutions
2.14.4 Miltenyi Bioindustry Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Miltenyi Bioindustry Recent Developments and Future Plans
2.15 Aldevron
2.15.1 Aldevron Details
2.15.2 Aldevron Major Business
2.15.3 Aldevron Viral Vector CDMO Services Product and Solutions
2.15.4 Aldevron Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Aldevron Recent Developments and Future Plans
2.16 Takara Bio
2.16.1 Takara Bio Details
2.16.2 Takara Bio Major Business
2.16.3 Takara Bio Viral Vector CDMO Services Product and Solutions
2.16.4 Takara Bio Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Takara Bio Recent Developments and Future Plans
2.17 Yposkesi
2.17.1 Yposkesi Details
2.17.2 Yposkesi Major Business
2.17.3 Yposkesi Viral Vector CDMO Services Product and Solutions
2.17.4 Yposkesi Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Yposkesi Recent Developments and Future Plans
2.18 Genezen
2.18.1 Genezen Details
2.18.2 Genezen Major Business
2.18.3 Genezen Viral Vector CDMO Services Product and Solutions
2.18.4 Genezen Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Genezen Recent Developments and Future Plans
2.19 GenScript ProBio
2.19.1 GenScript ProBio Details
2.19.2 GenScript ProBio Major Business
2.19.3 GenScript ProBio Viral Vector CDMO Services Product and Solutions
2.19.4 GenScript ProBio Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 GenScript ProBio Recent Developments and Future Plans
2.20 EurekaBio
2.20.1 EurekaBio Details
2.20.2 EurekaBio Major Business
2.20.3 EurekaBio Viral Vector CDMO Services Product and Solutions
2.20.4 EurekaBio Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 EurekaBio Recent Developments and Future Plans
2.21 Obio Technology
2.21.1 Obio Technology Details
2.21.2 Obio Technology Major Business
2.21.3 Obio Technology Viral Vector CDMO Services Product and Solutions
2.21.4 Obio Technology Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Obio Technology Recent Developments and Future Plans
2.22 GeneSail Biotech
2.22.1 GeneSail Biotech Details
2.22.2 GeneSail Biotech Major Business
2.22.3 GeneSail Biotech Viral Vector CDMO Services Product and Solutions
2.22.4 GeneSail Biotech Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.22.5 GeneSail Biotech Recent Developments and Future Plans
2.23 VectorBuilder
2.23.1 VectorBuilder Details
2.23.2 VectorBuilder Major Business
2.23.3 VectorBuilder Viral Vector CDMO Services Product and Solutions
2.23.4 VectorBuilder Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.23.5 VectorBuilder Recent Developments and Future Plans
2.24 WuXi ATU
2.24.1 WuXi ATU Details
2.24.2 WuXi ATU Major Business
2.24.3 WuXi ATU Viral Vector CDMO Services Product and Solutions
2.24.4 WuXi ATU Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.24.5 WuXi ATU Recent Developments and Future Plans
2.25 Ubrigene
2.25.1 Ubrigene Details
2.25.2 Ubrigene Major Business
2.25.3 Ubrigene Viral Vector CDMO Services Product and Solutions
2.25.4 Ubrigene Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.25.5 Ubrigene Recent Developments and Future Plans
2.26 Porton Biologics
2.26.1 Porton Biologics Details
2.26.2 Porton Biologics Major Business
2.26.3 Porton Biologics Viral Vector CDMO Services Product and Solutions
2.26.4 Porton Biologics Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.26.5 Porton Biologics Recent Developments and Future Plans
2.27 Pharmaron
2.27.1 Pharmaron Details
2.27.2 Pharmaron Major Business
2.27.3 Pharmaron Viral Vector CDMO Services Product and Solutions
2.27.4 Pharmaron Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.27.5 Pharmaron Recent Developments and Future Plans
2.28 PackGene Biotechnology
2.28.1 PackGene Biotechnology Details
2.28.2 PackGene Biotechnology Major Business
2.28.3 PackGene Biotechnology Viral Vector CDMO Services Product and Solutions
2.28.4 PackGene Biotechnology Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.28.5 PackGene Biotechnology Recent Developments and Future Plans
2.29 Hillgene
2.29.1 Hillgene Details
2.29.2 Hillgene Major Business
2.29.3 Hillgene Viral Vector CDMO Services Product and Solutions
2.29.4 Hillgene Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.29.5 Hillgene Recent Developments and Future Plans
2.30 Asymchem
2.30.1 Asymchem Details
2.30.2 Asymchem Major Business
2.30.3 Asymchem Viral Vector CDMO Services Product and Solutions
2.30.4 Asymchem Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.30.5 Asymchem Recent Developments and Future Plans
2.31 Exthera
2.31.1 Exthera Details
2.31.2 Exthera Major Business
2.31.3 Exthera Viral Vector CDMO Services Product and Solutions
2.31.4 Exthera Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.31.5 Exthera Recent Developments and Future Plans
2.32 Flash Therapeutics
2.32.1 Flash Therapeutics Details
2.32.2 Flash Therapeutics Major Business
2.32.3 Flash Therapeutics Viral Vector CDMO Services Product and Solutions
2.32.4 Flash Therapeutics Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.32.5 Flash Therapeutics Recent Developments and Future Plans
2.33 VIVEBiotech
2.33.1 VIVEBiotech Details
2.33.2 VIVEBiotech Major Business
2.33.3 VIVEBiotech Viral Vector CDMO Services Product and Solutions
2.33.4 VIVEBiotech Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.33.5 VIVEBiotech Recent Developments and Future Plans
2.34 FinVector
2.34.1 FinVector Details
2.34.2 FinVector Major Business
2.34.3 FinVector Viral Vector CDMO Services Product and Solutions
2.34.4 FinVector Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.34.5 FinVector Recent Developments and Future Plans
2.35 uBriGene
2.35.1 uBriGene Details
2.35.2 uBriGene Major Business
2.35.3 uBriGene Viral Vector CDMO Services Product and Solutions
2.35.4 uBriGene Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.35.5 uBriGene Recent Developments and Future Plans
2.36 Eurogentec
2.36.1 Eurogentec Details
2.36.2 Eurogentec Major Business
2.36.3 Eurogentec Viral Vector CDMO Services Product and Solutions
2.36.4 Eurogentec Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.36.5 Eurogentec Recent Developments and Future Plans
2.37 VGXI
2.37.1 VGXI Details
2.37.2 VGXI Major Business
2.37.3 VGXI Viral Vector CDMO Services Product and Solutions
2.37.4 VGXI Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.37.5 VGXI Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Viral Vector CDMO Services Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Viral Vector CDMO Services by Company Revenue
3.2.2 Top 3 Viral Vector CDMO Services Players Market Share in 2022
3.2.3 Top 6 Viral Vector CDMO Services Players Market Share in 2022
3.3 Viral Vector CDMO Services Market: Overall Company Footprint Analysis
3.3.1 Viral Vector CDMO Services Market: Region Footprint
3.3.2 Viral Vector CDMO Services Market: Company Product Type Footprint
3.3.3 Viral Vector CDMO Services Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Viral Vector CDMO Services Consumption Value and Market Share by Type (2018-2023)
4.2 Global Viral Vector CDMO Services Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Viral Vector CDMO Services Consumption Value Market Share by Application (2018-2023)
5.2 Global Viral Vector CDMO Services Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Viral Vector CDMO Services Consumption Value by Type (2018-2029)
6.2 North America Viral Vector CDMO Services Consumption Value by Application (2018-2029)
6.3 North America Viral Vector CDMO Services Market Size by Country
6.3.1 North America Viral Vector CDMO Services Consumption Value by Country (2018-2029)
6.3.2 United States Viral Vector CDMO Services Market Size and Forecast (2018-2029)
6.3.3 Canada Viral Vector CDMO Services Market Size and Forecast (2018-2029)
6.3.4 Mexico Viral Vector CDMO Services Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Viral Vector CDMO Services Consumption Value by Type (2018-2029)
7.2 Europe Viral Vector CDMO Services Consumption Value by Application (2018-2029)
7.3 Europe Viral Vector CDMO Services Market Size by Country
7.3.1 Europe Viral Vector CDMO Services Consumption Value by Country (2018-2029)
7.3.2 Germany Viral Vector CDMO Services Market Size and Forecast (2018-2029)
7.3.3 France Viral Vector CDMO Services Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Viral Vector CDMO Services Market Size and Forecast (2018-2029)
7.3.5 Russia Viral Vector CDMO Services Market Size and Forecast (2018-2029)
7.3.6 Italy Viral Vector CDMO Services Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Viral Vector CDMO Services Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Viral Vector CDMO Services Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Viral Vector CDMO Services Market Size by Region
8.3.1 Asia-Pacific Viral Vector CDMO Services Consumption Value by Region (2018-2029)
8.3.2 China Viral Vector CDMO Services Market Size and Forecast (2018-2029)
8.3.3 Japan Viral Vector CDMO Services Market Size and Forecast (2018-2029)
8.3.4 South Korea Viral Vector CDMO Services Market Size and Forecast (2018-2029)
8.3.5 India Viral Vector CDMO Services Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Viral Vector CDMO Services Market Size and Forecast (2018-2029)
8.3.7 Australia Viral Vector CDMO Services Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Viral Vector CDMO Services Consumption Value by Type (2018-2029)
9.2 South America Viral Vector CDMO Services Consumption Value by Application (2018-2029)
9.3 South America Viral Vector CDMO Services Market Size by Country
9.3.1 South America Viral Vector CDMO Services Consumption Value by Country (2018-2029)
9.3.2 Brazil Viral Vector CDMO Services Market Size and Forecast (2018-2029)
9.3.3 Argentina Viral Vector CDMO Services Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Viral Vector CDMO Services Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Viral Vector CDMO Services Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Viral Vector CDMO Services Market Size by Country
10.3.1 Middle East & Africa Viral Vector CDMO Services Consumption Value by Country (2018-2029)
10.3.2 Turkey Viral Vector CDMO Services Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Viral Vector CDMO Services Market Size and Forecast (2018-2029)
10.3.4 UAE Viral Vector CDMO Services Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Viral Vector CDMO Services Market Drivers
11.2 Viral Vector CDMO Services Market Restraints
11.3 Viral Vector CDMO Services Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Viral Vector CDMO Services Industry Chain
12.2 Viral Vector CDMO Services Upstream Analysis
12.3 Viral Vector CDMO Services Midstream Analysis
12.4 Viral Vector CDMO Services Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Viral Vector CDMO Services
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Viral Vector CDMO Services by Type
1.3.1 Overview: Global Viral Vector CDMO Services Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Viral Vector CDMO Services Consumption Value Market Share by Type in 2022
1.3.3 AAV
1.3.4 Lentivirus
1.3.5 Adenovirus
1.3.6 HSV
1.3.7 Others
1.4 Global Viral Vector CDMO Services Market by Application
1.4.1 Overview: Global Viral Vector CDMO Services Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Vaccine Development
1.4.3 Gene Therapy
1.4.4 Academic Scientific Research Institution
1.4.5 Others
1.5 Global Viral Vector CDMO Services Market Size & Forecast
1.6 Global Viral Vector CDMO Services Market Size and Forecast by Region
1.6.1 Global Viral Vector CDMO Services Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Viral Vector CDMO Services Market Size by Region, (2018-2029)
1.6.3 North America Viral Vector CDMO Services Market Size and Prospect (2018-2029)
1.6.4 Europe Viral Vector CDMO Services Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Viral Vector CDMO Services Market Size and Prospect (2018-2029)
1.6.6 South America Viral Vector CDMO Services Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Viral Vector CDMO Services Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Viral Vector CDMO Services Product and Solutions
2.1.4 Thermo Fisher Scientific Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.2 Lonza
2.2.1 Lonza Details
2.2.2 Lonza Major Business
2.2.3 Lonza Viral Vector CDMO Services Product and Solutions
2.2.4 Lonza Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Lonza Recent Developments and Future Plans
2.3 Catalent
2.3.1 Catalent Details
2.3.2 Catalent Major Business
2.3.3 Catalent Viral Vector CDMO Services Product and Solutions
2.3.4 Catalent Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Catalent Recent Developments and Future Plans
2.4 Charles River
2.4.1 Charles River Details
2.4.2 Charles River Major Business
2.4.3 Charles River Viral Vector CDMO Services Product and Solutions
2.4.4 Charles River Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Charles River Recent Developments and Future Plans
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business
2.5.3 Merck Viral Vector CDMO Services Product and Solutions
2.5.4 Merck Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Merck Recent Developments and Future Plans
2.6 SK pharmteco
2.6.1 SK pharmteco Details
2.6.2 SK pharmteco Major Business
2.6.3 SK pharmteco Viral Vector CDMO Services Product and Solutions
2.6.4 SK pharmteco Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 SK pharmteco Recent Developments and Future Plans
2.7 Oxford Biomedica
2.7.1 Oxford Biomedica Details
2.7.2 Oxford Biomedica Major Business
2.7.3 Oxford Biomedica Viral Vector CDMO Services Product and Solutions
2.7.4 Oxford Biomedica Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Oxford Biomedica Recent Developments and Future Plans
2.8 AGC Biologics?MolMed?
2.8.1 AGC Biologics?MolMed? Details
2.8.2 AGC Biologics?MolMed? Major Business
2.8.3 AGC Biologics?MolMed? Viral Vector CDMO Services Product and Solutions
2.8.4 AGC Biologics?MolMed? Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 AGC Biologics?MolMed? Recent Developments and Future Plans
2.9 Gene Universal
2.9.1 Gene Universal Details
2.9.2 Gene Universal Major Business
2.9.3 Gene Universal Viral Vector CDMO Services Product and Solutions
2.9.4 Gene Universal Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Gene Universal Recent Developments and Future Plans
2.10 Polyplus (Sartorius)
2.10.1 Polyplus (Sartorius) Details
2.10.2 Polyplus (Sartorius) Major Business
2.10.3 Polyplus (Sartorius) Viral Vector CDMO Services Product and Solutions
2.10.4 Polyplus (Sartorius) Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Polyplus (Sartorius) Recent Developments and Future Plans
2.11 CCRM
2.11.1 CCRM Details
2.11.2 CCRM Major Business
2.11.3 CCRM Viral Vector CDMO Services Product and Solutions
2.11.4 CCRM Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 CCRM Recent Developments and Future Plans
2.12 FUJIFILM Diosynth Biotechnologies
2.12.1 FUJIFILM Diosynth Biotechnologies Details
2.12.2 FUJIFILM Diosynth Biotechnologies Major Business
2.12.3 FUJIFILM Diosynth Biotechnologies Viral Vector CDMO Services Product and Solutions
2.12.4 FUJIFILM Diosynth Biotechnologies Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
2.13 Biovian
2.13.1 Biovian Details
2.13.2 Biovian Major Business
2.13.3 Biovian Viral Vector CDMO Services Product and Solutions
2.13.4 Biovian Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Biovian Recent Developments and Future Plans
2.14 Miltenyi Bioindustry
2.14.1 Miltenyi Bioindustry Details
2.14.2 Miltenyi Bioindustry Major Business
2.14.3 Miltenyi Bioindustry Viral Vector CDMO Services Product and Solutions
2.14.4 Miltenyi Bioindustry Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Miltenyi Bioindustry Recent Developments and Future Plans
2.15 Aldevron
2.15.1 Aldevron Details
2.15.2 Aldevron Major Business
2.15.3 Aldevron Viral Vector CDMO Services Product and Solutions
2.15.4 Aldevron Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Aldevron Recent Developments and Future Plans
2.16 Takara Bio
2.16.1 Takara Bio Details
2.16.2 Takara Bio Major Business
2.16.3 Takara Bio Viral Vector CDMO Services Product and Solutions
2.16.4 Takara Bio Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Takara Bio Recent Developments and Future Plans
2.17 Yposkesi
2.17.1 Yposkesi Details
2.17.2 Yposkesi Major Business
2.17.3 Yposkesi Viral Vector CDMO Services Product and Solutions
2.17.4 Yposkesi Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Yposkesi Recent Developments and Future Plans
2.18 Genezen
2.18.1 Genezen Details
2.18.2 Genezen Major Business
2.18.3 Genezen Viral Vector CDMO Services Product and Solutions
2.18.4 Genezen Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Genezen Recent Developments and Future Plans
2.19 GenScript ProBio
2.19.1 GenScript ProBio Details
2.19.2 GenScript ProBio Major Business
2.19.3 GenScript ProBio Viral Vector CDMO Services Product and Solutions
2.19.4 GenScript ProBio Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 GenScript ProBio Recent Developments and Future Plans
2.20 EurekaBio
2.20.1 EurekaBio Details
2.20.2 EurekaBio Major Business
2.20.3 EurekaBio Viral Vector CDMO Services Product and Solutions
2.20.4 EurekaBio Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 EurekaBio Recent Developments and Future Plans
2.21 Obio Technology
2.21.1 Obio Technology Details
2.21.2 Obio Technology Major Business
2.21.3 Obio Technology Viral Vector CDMO Services Product and Solutions
2.21.4 Obio Technology Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Obio Technology Recent Developments and Future Plans
2.22 GeneSail Biotech
2.22.1 GeneSail Biotech Details
2.22.2 GeneSail Biotech Major Business
2.22.3 GeneSail Biotech Viral Vector CDMO Services Product and Solutions
2.22.4 GeneSail Biotech Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.22.5 GeneSail Biotech Recent Developments and Future Plans
2.23 VectorBuilder
2.23.1 VectorBuilder Details
2.23.2 VectorBuilder Major Business
2.23.3 VectorBuilder Viral Vector CDMO Services Product and Solutions
2.23.4 VectorBuilder Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.23.5 VectorBuilder Recent Developments and Future Plans
2.24 WuXi ATU
2.24.1 WuXi ATU Details
2.24.2 WuXi ATU Major Business
2.24.3 WuXi ATU Viral Vector CDMO Services Product and Solutions
2.24.4 WuXi ATU Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.24.5 WuXi ATU Recent Developments and Future Plans
2.25 Ubrigene
2.25.1 Ubrigene Details
2.25.2 Ubrigene Major Business
2.25.3 Ubrigene Viral Vector CDMO Services Product and Solutions
2.25.4 Ubrigene Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.25.5 Ubrigene Recent Developments and Future Plans
2.26 Porton Biologics
2.26.1 Porton Biologics Details
2.26.2 Porton Biologics Major Business
2.26.3 Porton Biologics Viral Vector CDMO Services Product and Solutions
2.26.4 Porton Biologics Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.26.5 Porton Biologics Recent Developments and Future Plans
2.27 Pharmaron
2.27.1 Pharmaron Details
2.27.2 Pharmaron Major Business
2.27.3 Pharmaron Viral Vector CDMO Services Product and Solutions
2.27.4 Pharmaron Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.27.5 Pharmaron Recent Developments and Future Plans
2.28 PackGene Biotechnology
2.28.1 PackGene Biotechnology Details
2.28.2 PackGene Biotechnology Major Business
2.28.3 PackGene Biotechnology Viral Vector CDMO Services Product and Solutions
2.28.4 PackGene Biotechnology Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.28.5 PackGene Biotechnology Recent Developments and Future Plans
2.29 Hillgene
2.29.1 Hillgene Details
2.29.2 Hillgene Major Business
2.29.3 Hillgene Viral Vector CDMO Services Product and Solutions
2.29.4 Hillgene Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.29.5 Hillgene Recent Developments and Future Plans
2.30 Asymchem
2.30.1 Asymchem Details
2.30.2 Asymchem Major Business
2.30.3 Asymchem Viral Vector CDMO Services Product and Solutions
2.30.4 Asymchem Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.30.5 Asymchem Recent Developments and Future Plans
2.31 Exthera
2.31.1 Exthera Details
2.31.2 Exthera Major Business
2.31.3 Exthera Viral Vector CDMO Services Product and Solutions
2.31.4 Exthera Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.31.5 Exthera Recent Developments and Future Plans
2.32 Flash Therapeutics
2.32.1 Flash Therapeutics Details
2.32.2 Flash Therapeutics Major Business
2.32.3 Flash Therapeutics Viral Vector CDMO Services Product and Solutions
2.32.4 Flash Therapeutics Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.32.5 Flash Therapeutics Recent Developments and Future Plans
2.33 VIVEBiotech
2.33.1 VIVEBiotech Details
2.33.2 VIVEBiotech Major Business
2.33.3 VIVEBiotech Viral Vector CDMO Services Product and Solutions
2.33.4 VIVEBiotech Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.33.5 VIVEBiotech Recent Developments and Future Plans
2.34 FinVector
2.34.1 FinVector Details
2.34.2 FinVector Major Business
2.34.3 FinVector Viral Vector CDMO Services Product and Solutions
2.34.4 FinVector Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.34.5 FinVector Recent Developments and Future Plans
2.35 uBriGene
2.35.1 uBriGene Details
2.35.2 uBriGene Major Business
2.35.3 uBriGene Viral Vector CDMO Services Product and Solutions
2.35.4 uBriGene Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.35.5 uBriGene Recent Developments and Future Plans
2.36 Eurogentec
2.36.1 Eurogentec Details
2.36.2 Eurogentec Major Business
2.36.3 Eurogentec Viral Vector CDMO Services Product and Solutions
2.36.4 Eurogentec Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.36.5 Eurogentec Recent Developments and Future Plans
2.37 VGXI
2.37.1 VGXI Details
2.37.2 VGXI Major Business
2.37.3 VGXI Viral Vector CDMO Services Product and Solutions
2.37.4 VGXI Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.37.5 VGXI Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Viral Vector CDMO Services Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Viral Vector CDMO Services by Company Revenue
3.2.2 Top 3 Viral Vector CDMO Services Players Market Share in 2022
3.2.3 Top 6 Viral Vector CDMO Services Players Market Share in 2022
3.3 Viral Vector CDMO Services Market: Overall Company Footprint Analysis
3.3.1 Viral Vector CDMO Services Market: Region Footprint
3.3.2 Viral Vector CDMO Services Market: Company Product Type Footprint
3.3.3 Viral Vector CDMO Services Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Viral Vector CDMO Services Consumption Value and Market Share by Type (2018-2023)
4.2 Global Viral Vector CDMO Services Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Viral Vector CDMO Services Consumption Value Market Share by Application (2018-2023)
5.2 Global Viral Vector CDMO Services Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Viral Vector CDMO Services Consumption Value by Type (2018-2029)
6.2 North America Viral Vector CDMO Services Consumption Value by Application (2018-2029)
6.3 North America Viral Vector CDMO Services Market Size by Country
6.3.1 North America Viral Vector CDMO Services Consumption Value by Country (2018-2029)
6.3.2 United States Viral Vector CDMO Services Market Size and Forecast (2018-2029)
6.3.3 Canada Viral Vector CDMO Services Market Size and Forecast (2018-2029)
6.3.4 Mexico Viral Vector CDMO Services Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Viral Vector CDMO Services Consumption Value by Type (2018-2029)
7.2 Europe Viral Vector CDMO Services Consumption Value by Application (2018-2029)
7.3 Europe Viral Vector CDMO Services Market Size by Country
7.3.1 Europe Viral Vector CDMO Services Consumption Value by Country (2018-2029)
7.3.2 Germany Viral Vector CDMO Services Market Size and Forecast (2018-2029)
7.3.3 France Viral Vector CDMO Services Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Viral Vector CDMO Services Market Size and Forecast (2018-2029)
7.3.5 Russia Viral Vector CDMO Services Market Size and Forecast (2018-2029)
7.3.6 Italy Viral Vector CDMO Services Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Viral Vector CDMO Services Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Viral Vector CDMO Services Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Viral Vector CDMO Services Market Size by Region
8.3.1 Asia-Pacific Viral Vector CDMO Services Consumption Value by Region (2018-2029)
8.3.2 China Viral Vector CDMO Services Market Size and Forecast (2018-2029)
8.3.3 Japan Viral Vector CDMO Services Market Size and Forecast (2018-2029)
8.3.4 South Korea Viral Vector CDMO Services Market Size and Forecast (2018-2029)
8.3.5 India Viral Vector CDMO Services Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Viral Vector CDMO Services Market Size and Forecast (2018-2029)
8.3.7 Australia Viral Vector CDMO Services Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Viral Vector CDMO Services Consumption Value by Type (2018-2029)
9.2 South America Viral Vector CDMO Services Consumption Value by Application (2018-2029)
9.3 South America Viral Vector CDMO Services Market Size by Country
9.3.1 South America Viral Vector CDMO Services Consumption Value by Country (2018-2029)
9.3.2 Brazil Viral Vector CDMO Services Market Size and Forecast (2018-2029)
9.3.3 Argentina Viral Vector CDMO Services Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Viral Vector CDMO Services Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Viral Vector CDMO Services Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Viral Vector CDMO Services Market Size by Country
10.3.1 Middle East & Africa Viral Vector CDMO Services Consumption Value by Country (2018-2029)
10.3.2 Turkey Viral Vector CDMO Services Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Viral Vector CDMO Services Market Size and Forecast (2018-2029)
10.3.4 UAE Viral Vector CDMO Services Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Viral Vector CDMO Services Market Drivers
11.2 Viral Vector CDMO Services Market Restraints
11.3 Viral Vector CDMO Services Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Viral Vector CDMO Services Industry Chain
12.2 Viral Vector CDMO Services Upstream Analysis
12.3 Viral Vector CDMO Services Midstream Analysis
12.4 Viral Vector CDMO Services Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Viral Vector CDMO Services Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Viral Vector CDMO Services Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Viral Vector CDMO Services Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Viral Vector CDMO Services Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 6. Thermo Fisher Scientific Major Business
Table 7. Thermo Fisher Scientific Viral Vector CDMO Services Product and Solutions
Table 8. Thermo Fisher Scientific Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Thermo Fisher Scientific Recent Developments and Future Plans
Table 10. Lonza Company Information, Head Office, and Major Competitors
Table 11. Lonza Major Business
Table 12. Lonza Viral Vector CDMO Services Product and Solutions
Table 13. Lonza Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Lonza Recent Developments and Future Plans
Table 15. Catalent Company Information, Head Office, and Major Competitors
Table 16. Catalent Major Business
Table 17. Catalent Viral Vector CDMO Services Product and Solutions
Table 18. Catalent Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Catalent Recent Developments and Future Plans
Table 20. Charles River Company Information, Head Office, and Major Competitors
Table 21. Charles River Major Business
Table 22. Charles River Viral Vector CDMO Services Product and Solutions
Table 23. Charles River Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Charles River Recent Developments and Future Plans
Table 25. Merck Company Information, Head Office, and Major Competitors
Table 26. Merck Major Business
Table 27. Merck Viral Vector CDMO Services Product and Solutions
Table 28. Merck Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Merck Recent Developments and Future Plans
Table 30. SK pharmteco Company Information, Head Office, and Major Competitors
Table 31. SK pharmteco Major Business
Table 32. SK pharmteco Viral Vector CDMO Services Product and Solutions
Table 33. SK pharmteco Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. SK pharmteco Recent Developments and Future Plans
Table 35. Oxford Biomedica Company Information, Head Office, and Major Competitors
Table 36. Oxford Biomedica Major Business
Table 37. Oxford Biomedica Viral Vector CDMO Services Product and Solutions
Table 38. Oxford Biomedica Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Oxford Biomedica Recent Developments and Future Plans
Table 40. AGC Biologics?MolMed? Company Information, Head Office, and Major Competitors
Table 41. AGC Biologics?MolMed? Major Business
Table 42. AGC Biologics?MolMed? Viral Vector CDMO Services Product and Solutions
Table 43. AGC Biologics?MolMed? Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. AGC Biologics?MolMed? Recent Developments and Future Plans
Table 45. Gene Universal Company Information, Head Office, and Major Competitors
Table 46. Gene Universal Major Business
Table 47. Gene Universal Viral Vector CDMO Services Product and Solutions
Table 48. Gene Universal Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Gene Universal Recent Developments and Future Plans
Table 50. Polyplus (Sartorius) Company Information, Head Office, and Major Competitors
Table 51. Polyplus (Sartorius) Major Business
Table 52. Polyplus (Sartorius) Viral Vector CDMO Services Product and Solutions
Table 53. Polyplus (Sartorius) Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Polyplus (Sartorius) Recent Developments and Future Plans
Table 55. CCRM Company Information, Head Office, and Major Competitors
Table 56. CCRM Major Business
Table 57. CCRM Viral Vector CDMO Services Product and Solutions
Table 58. CCRM Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. CCRM Recent Developments and Future Plans
Table 60. FUJIFILM Diosynth Biotechnologies Company Information, Head Office, and Major Competitors
Table 61. FUJIFILM Diosynth Biotechnologies Major Business
Table 62. FUJIFILM Diosynth Biotechnologies Viral Vector CDMO Services Product and Solutions
Table 63. FUJIFILM Diosynth Biotechnologies Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
Table 65. Biovian Company Information, Head Office, and Major Competitors
Table 66. Biovian Major Business
Table 67. Biovian Viral Vector CDMO Services Product and Solutions
Table 68. Biovian Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Biovian Recent Developments and Future Plans
Table 70. Miltenyi Bioindustry Company Information, Head Office, and Major Competitors
Table 71. Miltenyi Bioindustry Major Business
Table 72. Miltenyi Bioindustry Viral Vector CDMO Services Product and Solutions
Table 73. Miltenyi Bioindustry Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Miltenyi Bioindustry Recent Developments and Future Plans
Table 75. Aldevron Company Information, Head Office, and Major Competitors
Table 76. Aldevron Major Business
Table 77. Aldevron Viral Vector CDMO Services Product and Solutions
Table 78. Aldevron Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Aldevron Recent Developments and Future Plans
Table 80. Takara Bio Company Information, Head Office, and Major Competitors
Table 81. Takara Bio Major Business
Table 82. Takara Bio Viral Vector CDMO Services Product and Solutions
Table 83. Takara Bio Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Takara Bio Recent Developments and Future Plans
Table 85. Yposkesi Company Information, Head Office, and Major Competitors
Table 86. Yposkesi Major Business
Table 87. Yposkesi Viral Vector CDMO Services Product and Solutions
Table 88. Yposkesi Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Yposkesi Recent Developments and Future Plans
Table 90. Genezen Company Information, Head Office, and Major Competitors
Table 91. Genezen Major Business
Table 92. Genezen Viral Vector CDMO Services Product and Solutions
Table 93. Genezen Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Genezen Recent Developments and Future Plans
Table 95. GenScript ProBio Company Information, Head Office, and Major Competitors
Table 96. GenScript ProBio Major Business
Table 97. GenScript ProBio Viral Vector CDMO Services Product and Solutions
Table 98. GenScript ProBio Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. GenScript ProBio Recent Developments and Future Plans
Table 100. EurekaBio Company Information, Head Office, and Major Competitors
Table 101. EurekaBio Major Business
Table 102. EurekaBio Viral Vector CDMO Services Product and Solutions
Table 103. EurekaBio Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. EurekaBio Recent Developments and Future Plans
Table 105. Obio Technology Company Information, Head Office, and Major Competitors
Table 106. Obio Technology Major Business
Table 107. Obio Technology Viral Vector CDMO Services Product and Solutions
Table 108. Obio Technology Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 109. Obio Technology Recent Developments and Future Plans
Table 110. GeneSail Biotech Company Information, Head Office, and Major Competitors
Table 111. GeneSail Biotech Major Business
Table 112. GeneSail Biotech Viral Vector CDMO Services Product and Solutions
Table 113. GeneSail Biotech Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 114. GeneSail Biotech Recent Developments and Future Plans
Table 115. VectorBuilder Company Information, Head Office, and Major Competitors
Table 116. VectorBuilder Major Business
Table 117. VectorBuilder Viral Vector CDMO Services Product and Solutions
Table 118. VectorBuilder Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. VectorBuilder Recent Developments and Future Plans
Table 120. WuXi ATU Company Information, Head Office, and Major Competitors
Table 121. WuXi ATU Major Business
Table 122. WuXi ATU Viral Vector CDMO Services Product and Solutions
Table 123. WuXi ATU Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 124. WuXi ATU Recent Developments and Future Plans
Table 125. Ubrigene Company Information, Head Office, and Major Competitors
Table 126. Ubrigene Major Business
Table 127. Ubrigene Viral Vector CDMO Services Product and Solutions
Table 128. Ubrigene Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 129. Ubrigene Recent Developments and Future Plans
Table 130. Porton Biologics Company Information, Head Office, and Major Competitors
Table 131. Porton Biologics Major Business
Table 132. Porton Biologics Viral Vector CDMO Services Product and Solutions
Table 133. Porton Biologics Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 134. Porton Biologics Recent Developments and Future Plans
Table 135. Pharmaron Company Information, Head Office, and Major Competitors
Table 136. Pharmaron Major Business
Table 137. Pharmaron Viral Vector CDMO Services Product and Solutions
Table 138. Pharmaron Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 139. Pharmaron Recent Developments and Future Plans
Table 140. PackGene Biotechnology Company Information, Head Office, and Major Competitors
Table 141. PackGene Biotechnology Major Business
Table 142. PackGene Biotechnology Viral Vector CDMO Services Product and Solutions
Table 143. PackGene Biotechnology Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 144. PackGene Biotechnology Recent Developments and Future Plans
Table 145. Hillgene Company Information, Head Office, and Major Competitors
Table 146. Hillgene Major Business
Table 147. Hillgene Viral Vector CDMO Services Product and Solutions
Table 148. Hillgene Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Hillgene Recent Developments and Future Plans
Table 150. Asymchem Company Information, Head Office, and Major Competitors
Table 151. Asymchem Major Business
Table 152. Asymchem Viral Vector CDMO Services Product and Solutions
Table 153. Asymchem Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 154. Asymchem Recent Developments and Future Plans
Table 155. Exthera Company Information, Head Office, and Major Competitors
Table 156. Exthera Major Business
Table 157. Exthera Viral Vector CDMO Services Product and Solutions
Table 158. Exthera Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 159. Exthera Recent Developments and Future Plans
Table 160. Flash Therapeutics Company Information, Head Office, and Major Competitors
Table 161. Flash Therapeutics Major Business
Table 162. Flash Therapeutics Viral Vector CDMO Services Product and Solutions
Table 163. Flash Therapeutics Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 164. Flash Therapeutics Recent Developments and Future Plans
Table 165. VIVEBiotech Company Information, Head Office, and Major Competitors
Table 166. VIVEBiotech Major Business
Table 167. VIVEBiotech Viral Vector CDMO Services Product and Solutions
Table 168. VIVEBiotech Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 169. VIVEBiotech Recent Developments and Future Plans
Table 170. FinVector Company Information, Head Office, and Major Competitors
Table 171. FinVector Major Business
Table 172. FinVector Viral Vector CDMO Services Product and Solutions
Table 173. FinVector Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 174. FinVector Recent Developments and Future Plans
Table 175. uBriGene Company Information, Head Office, and Major Competitors
Table 176. uBriGene Major Business
Table 177. uBriGene Viral Vector CDMO Services Product and Solutions
Table 178. uBriGene Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 179. uBriGene Recent Developments and Future Plans
Table 180. Eurogentec Company Information, Head Office, and Major Competitors
Table 181. Eurogentec Major Business
Table 182. Eurogentec Viral Vector CDMO Services Product and Solutions
Table 183. Eurogentec Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 184. Eurogentec Recent Developments and Future Plans
Table 185. VGXI Company Information, Head Office, and Major Competitors
Table 186. VGXI Major Business
Table 187. VGXI Viral Vector CDMO Services Product and Solutions
Table 188. VGXI Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 189. VGXI Recent Developments and Future Plans
Table 190. Global Viral Vector CDMO Services Revenue (USD Million) by Players (2018-2023)
Table 191. Global Viral Vector CDMO Services Revenue Share by Players (2018-2023)
Table 192. Breakdown of Viral Vector CDMO Services by Company Type (Tier 1, Tier 2, and Tier 3)
Table 193. Market Position of Players in Viral Vector CDMO Services, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 194. Head Office of Key Viral Vector CDMO Services Players
Table 195. Viral Vector CDMO Services Market: Company Product Type Footprint
Table 196. Viral Vector CDMO Services Market: Company Product Application Footprint
Table 197. Viral Vector CDMO Services New Market Entrants and Barriers to Market Entry
Table 198. Viral Vector CDMO Services Mergers, Acquisition, Agreements, and Collaborations
Table 199. Global Viral Vector CDMO Services Consumption Value (USD Million) by Type (2018-2023)
Table 200. Global Viral Vector CDMO Services Consumption Value Share by Type (2018-2023)
Table 201. Global Viral Vector CDMO Services Consumption Value Forecast by Type (2024-2029)
Table 202. Global Viral Vector CDMO Services Consumption Value by Application (2018-2023)
Table 203. Global Viral Vector CDMO Services Consumption Value Forecast by Application (2024-2029)
Table 204. North America Viral Vector CDMO Services Consumption Value by Type (2018-2023) & (USD Million)
Table 205. North America Viral Vector CDMO Services Consumption Value by Type (2024-2029) & (USD Million)
Table 206. North America Viral Vector CDMO Services Consumption Value by Application (2018-2023) & (USD Million)
Table 207. North America Viral Vector CDMO Services Consumption Value by Application (2024-2029) & (USD Million)
Table 208. North America Viral Vector CDMO Services Consumption Value by Country (2018-2023) & (USD Million)
Table 209. North America Viral Vector CDMO Services Consumption Value by Country (2024-2029) & (USD Million)
Table 210. Europe Viral Vector CDMO Services Consumption Value by Type (2018-2023) & (USD Million)
Table 211. Europe Viral Vector CDMO Services Consumption Value by Type (2024-2029) & (USD Million)
Table 212. Europe Viral Vector CDMO Services Consumption Value by Application (2018-2023) & (USD Million)
Table 213. Europe Viral Vector CDMO Services Consumption Value by Application (2024-2029) & (USD Million)
Table 214. Europe Viral Vector CDMO Services Consumption Value by Country (2018-2023) & (USD Million)
Table 215. Europe Viral Vector CDMO Services Consumption Value by Country (2024-2029) & (USD Million)
Table 216. Asia-Pacific Viral Vector CDMO Services Consumption Value by Type (2018-2023) & (USD Million)
Table 217. Asia-Pacific Viral Vector CDMO Services Consumption Value by Type (2024-2029) & (USD Million)
Table 218. Asia-Pacific Viral Vector CDMO Services Consumption Value by Application (2018-2023) & (USD Million)
Table 219. Asia-Pacific Viral Vector CDMO Services Consumption Value by Application (2024-2029) & (USD Million)
Table 220. Asia-Pacific Viral Vector CDMO Services Consumption Value by Region (2018-2023) & (USD Million)
Table 221. Asia-Pacific Viral Vector CDMO Services Consumption Value by Region (2024-2029) & (USD Million)
Table 222. South America Viral Vector CDMO Services Consumption Value by Type (2018-2023) & (USD Million)
Table 223. South America Viral Vector CDMO Services Consumption Value by Type (2024-2029) & (USD Million)
Table 224. South America Viral Vector CDMO Services Consumption Value by Application (2018-2023) & (USD Million)
Table 225. South America Viral Vector CDMO Services Consumption Value by Application (2024-2029) & (USD Million)
Table 226. South America Viral Vector CDMO Services Consumption Value by Country (2018-2023) & (USD Million)
Table 227. South America Viral Vector CDMO Services Consumption Value by Country (2024-2029) & (USD Million)
Table 228. Middle East & Africa Viral Vector CDMO Services Consumption Value by Type (2018-2023) & (USD Million)
Table 229. Middle East & Africa Viral Vector CDMO Services Consumption Value by Type (2024-2029) & (USD Million)
Table 230. Middle East & Africa Viral Vector CDMO Services Consumption Value by Application (2018-2023) & (USD Million)
Table 231. Middle East & Africa Viral Vector CDMO Services Consumption Value by Application (2024-2029) & (USD Million)
Table 232. Middle East & Africa Viral Vector CDMO Services Consumption Value by Country (2018-2023) & (USD Million)
Table 233. Middle East & Africa Viral Vector CDMO Services Consumption Value by Country (2024-2029) & (USD Million)
Table 234. Viral Vector CDMO Services Raw Material
Table 235. Key Suppliers of Viral Vector CDMO Services Raw Materials
LIST OF FIGURE
s
Figure 1. Viral Vector CDMO Services Picture
Figure 2. Global Viral Vector CDMO Services Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Viral Vector CDMO Services Consumption Value Market Share by Type in 2022
Figure 4. AAV
Figure 5. Lentivirus
Figure 6. Adenovirus
Figure 7. HSV
Figure 8. Others
Figure 9. Global Viral Vector CDMO Services Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 10. Viral Vector CDMO Services Consumption Value Market Share by Application in 2022
Figure 11. Vaccine Development Picture
Figure 12. Gene Therapy Picture
Figure 13. Academic Scientific Research Institution Picture
Figure 14. Others Picture
Figure 15. Global Viral Vector CDMO Services Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Viral Vector CDMO Services Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Market Viral Vector CDMO Services Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 18. Global Viral Vector CDMO Services Consumption Value Market Share by Region (2018-2029)
Figure 19. Global Viral Vector CDMO Services Consumption Value Market Share by Region in 2022
Figure 20. North America Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 21. Europe Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 22. Asia-Pacific Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 23. South America Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 24. Middle East and Africa Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 25. Global Viral Vector CDMO Services Revenue Share by Players in 2022
Figure 26. Viral Vector CDMO Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 27. Global Top 3 Players Viral Vector CDMO Services Market Share in 2022
Figure 28. Global Top 6 Players Viral Vector CDMO Services Market Share in 2022
Figure 29. Global Viral Vector CDMO Services Consumption Value Share by Type (2018-2023)
Figure 30. Global Viral Vector CDMO Services Market Share Forecast by Type (2024-2029)
Figure 31. Global Viral Vector CDMO Services Consumption Value Share by Application (2018-2023)
Figure 32. Global Viral Vector CDMO Services Market Share Forecast by Application (2024-2029)
Figure 33. North America Viral Vector CDMO Services Consumption Value Market Share by Type (2018-2029)
Figure 34. North America Viral Vector CDMO Services Consumption Value Market Share by Application (2018-2029)
Figure 35. North America Viral Vector CDMO Services Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 37. Canada Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 38. Mexico Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 39. Europe Viral Vector CDMO Services Consumption Value Market Share by Type (2018-2029)
Figure 40. Europe Viral Vector CDMO Services Consumption Value Market Share by Application (2018-2029)
Figure 41. Europe Viral Vector CDMO Services Consumption Value Market Share by Country (2018-2029)
Figure 42. Germany Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 43. France Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 44. United Kingdom Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 45. Russia Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 46. Italy Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 47. Asia-Pacific Viral Vector CDMO Services Consumption Value Market Share by Type (2018-2029)
Figure 48. Asia-Pacific Viral Vector CDMO Services Consumption Value Market Share by Application (2018-2029)
Figure 49. Asia-Pacific Viral Vector CDMO Services Consumption Value Market Share by Region (2018-2029)
Figure 50. China Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 51. Japan Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 52. South Korea Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 53. India Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 54. Southeast Asia Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 55. Australia Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 56. South America Viral Vector CDMO Services Consumption Value Market Share by Type (2018-2029)
Figure 57. South America Viral Vector CDMO Services Consumption Value Market Share by Application (2018-2029)
Figure 58. South America Viral Vector CDMO Services Consumption Value Market Share by Country (2018-2029)
Figure 59. Brazil Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 60. Argentina Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 61. Middle East and Africa Viral Vector CDMO Services Consumption Value Market Share by Type (2018-2029)
Figure 62. Middle East and Africa Viral Vector CDMO Services Consumption Value Market Share by Application (2018-2029)
Figure 63. Middle East and Africa Viral Vector CDMO Services Consumption Value Market Share by Country (2018-2029)
Figure 64. Turkey Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 65. Saudi Arabia Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 66. UAE Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 67. Viral Vector CDMO Services Market Drivers
Figure 68. Viral Vector CDMO Services Market Restraints
Figure 69. Viral Vector CDMO Services Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Manufacturing Cost Structure Analysis of Viral Vector CDMO Services in 2022
Figure 72. Manufacturing Process Analysis of Viral Vector CDMO Services
Figure 73. Viral Vector CDMO Services Industrial Chain
Figure 74. Methodology
Figure 75. Research Process and Data Source
Table 1. Global Viral Vector CDMO Services Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Viral Vector CDMO Services Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Viral Vector CDMO Services Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Viral Vector CDMO Services Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 6. Thermo Fisher Scientific Major Business
Table 7. Thermo Fisher Scientific Viral Vector CDMO Services Product and Solutions
Table 8. Thermo Fisher Scientific Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Thermo Fisher Scientific Recent Developments and Future Plans
Table 10. Lonza Company Information, Head Office, and Major Competitors
Table 11. Lonza Major Business
Table 12. Lonza Viral Vector CDMO Services Product and Solutions
Table 13. Lonza Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Lonza Recent Developments and Future Plans
Table 15. Catalent Company Information, Head Office, and Major Competitors
Table 16. Catalent Major Business
Table 17. Catalent Viral Vector CDMO Services Product and Solutions
Table 18. Catalent Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Catalent Recent Developments and Future Plans
Table 20. Charles River Company Information, Head Office, and Major Competitors
Table 21. Charles River Major Business
Table 22. Charles River Viral Vector CDMO Services Product and Solutions
Table 23. Charles River Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Charles River Recent Developments and Future Plans
Table 25. Merck Company Information, Head Office, and Major Competitors
Table 26. Merck Major Business
Table 27. Merck Viral Vector CDMO Services Product and Solutions
Table 28. Merck Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Merck Recent Developments and Future Plans
Table 30. SK pharmteco Company Information, Head Office, and Major Competitors
Table 31. SK pharmteco Major Business
Table 32. SK pharmteco Viral Vector CDMO Services Product and Solutions
Table 33. SK pharmteco Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. SK pharmteco Recent Developments and Future Plans
Table 35. Oxford Biomedica Company Information, Head Office, and Major Competitors
Table 36. Oxford Biomedica Major Business
Table 37. Oxford Biomedica Viral Vector CDMO Services Product and Solutions
Table 38. Oxford Biomedica Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Oxford Biomedica Recent Developments and Future Plans
Table 40. AGC Biologics?MolMed? Company Information, Head Office, and Major Competitors
Table 41. AGC Biologics?MolMed? Major Business
Table 42. AGC Biologics?MolMed? Viral Vector CDMO Services Product and Solutions
Table 43. AGC Biologics?MolMed? Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. AGC Biologics?MolMed? Recent Developments and Future Plans
Table 45. Gene Universal Company Information, Head Office, and Major Competitors
Table 46. Gene Universal Major Business
Table 47. Gene Universal Viral Vector CDMO Services Product and Solutions
Table 48. Gene Universal Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Gene Universal Recent Developments and Future Plans
Table 50. Polyplus (Sartorius) Company Information, Head Office, and Major Competitors
Table 51. Polyplus (Sartorius) Major Business
Table 52. Polyplus (Sartorius) Viral Vector CDMO Services Product and Solutions
Table 53. Polyplus (Sartorius) Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Polyplus (Sartorius) Recent Developments and Future Plans
Table 55. CCRM Company Information, Head Office, and Major Competitors
Table 56. CCRM Major Business
Table 57. CCRM Viral Vector CDMO Services Product and Solutions
Table 58. CCRM Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. CCRM Recent Developments and Future Plans
Table 60. FUJIFILM Diosynth Biotechnologies Company Information, Head Office, and Major Competitors
Table 61. FUJIFILM Diosynth Biotechnologies Major Business
Table 62. FUJIFILM Diosynth Biotechnologies Viral Vector CDMO Services Product and Solutions
Table 63. FUJIFILM Diosynth Biotechnologies Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
Table 65. Biovian Company Information, Head Office, and Major Competitors
Table 66. Biovian Major Business
Table 67. Biovian Viral Vector CDMO Services Product and Solutions
Table 68. Biovian Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Biovian Recent Developments and Future Plans
Table 70. Miltenyi Bioindustry Company Information, Head Office, and Major Competitors
Table 71. Miltenyi Bioindustry Major Business
Table 72. Miltenyi Bioindustry Viral Vector CDMO Services Product and Solutions
Table 73. Miltenyi Bioindustry Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Miltenyi Bioindustry Recent Developments and Future Plans
Table 75. Aldevron Company Information, Head Office, and Major Competitors
Table 76. Aldevron Major Business
Table 77. Aldevron Viral Vector CDMO Services Product and Solutions
Table 78. Aldevron Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Aldevron Recent Developments and Future Plans
Table 80. Takara Bio Company Information, Head Office, and Major Competitors
Table 81. Takara Bio Major Business
Table 82. Takara Bio Viral Vector CDMO Services Product and Solutions
Table 83. Takara Bio Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Takara Bio Recent Developments and Future Plans
Table 85. Yposkesi Company Information, Head Office, and Major Competitors
Table 86. Yposkesi Major Business
Table 87. Yposkesi Viral Vector CDMO Services Product and Solutions
Table 88. Yposkesi Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Yposkesi Recent Developments and Future Plans
Table 90. Genezen Company Information, Head Office, and Major Competitors
Table 91. Genezen Major Business
Table 92. Genezen Viral Vector CDMO Services Product and Solutions
Table 93. Genezen Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Genezen Recent Developments and Future Plans
Table 95. GenScript ProBio Company Information, Head Office, and Major Competitors
Table 96. GenScript ProBio Major Business
Table 97. GenScript ProBio Viral Vector CDMO Services Product and Solutions
Table 98. GenScript ProBio Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. GenScript ProBio Recent Developments and Future Plans
Table 100. EurekaBio Company Information, Head Office, and Major Competitors
Table 101. EurekaBio Major Business
Table 102. EurekaBio Viral Vector CDMO Services Product and Solutions
Table 103. EurekaBio Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. EurekaBio Recent Developments and Future Plans
Table 105. Obio Technology Company Information, Head Office, and Major Competitors
Table 106. Obio Technology Major Business
Table 107. Obio Technology Viral Vector CDMO Services Product and Solutions
Table 108. Obio Technology Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 109. Obio Technology Recent Developments and Future Plans
Table 110. GeneSail Biotech Company Information, Head Office, and Major Competitors
Table 111. GeneSail Biotech Major Business
Table 112. GeneSail Biotech Viral Vector CDMO Services Product and Solutions
Table 113. GeneSail Biotech Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 114. GeneSail Biotech Recent Developments and Future Plans
Table 115. VectorBuilder Company Information, Head Office, and Major Competitors
Table 116. VectorBuilder Major Business
Table 117. VectorBuilder Viral Vector CDMO Services Product and Solutions
Table 118. VectorBuilder Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. VectorBuilder Recent Developments and Future Plans
Table 120. WuXi ATU Company Information, Head Office, and Major Competitors
Table 121. WuXi ATU Major Business
Table 122. WuXi ATU Viral Vector CDMO Services Product and Solutions
Table 123. WuXi ATU Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 124. WuXi ATU Recent Developments and Future Plans
Table 125. Ubrigene Company Information, Head Office, and Major Competitors
Table 126. Ubrigene Major Business
Table 127. Ubrigene Viral Vector CDMO Services Product and Solutions
Table 128. Ubrigene Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 129. Ubrigene Recent Developments and Future Plans
Table 130. Porton Biologics Company Information, Head Office, and Major Competitors
Table 131. Porton Biologics Major Business
Table 132. Porton Biologics Viral Vector CDMO Services Product and Solutions
Table 133. Porton Biologics Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 134. Porton Biologics Recent Developments and Future Plans
Table 135. Pharmaron Company Information, Head Office, and Major Competitors
Table 136. Pharmaron Major Business
Table 137. Pharmaron Viral Vector CDMO Services Product and Solutions
Table 138. Pharmaron Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 139. Pharmaron Recent Developments and Future Plans
Table 140. PackGene Biotechnology Company Information, Head Office, and Major Competitors
Table 141. PackGene Biotechnology Major Business
Table 142. PackGene Biotechnology Viral Vector CDMO Services Product and Solutions
Table 143. PackGene Biotechnology Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 144. PackGene Biotechnology Recent Developments and Future Plans
Table 145. Hillgene Company Information, Head Office, and Major Competitors
Table 146. Hillgene Major Business
Table 147. Hillgene Viral Vector CDMO Services Product and Solutions
Table 148. Hillgene Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Hillgene Recent Developments and Future Plans
Table 150. Asymchem Company Information, Head Office, and Major Competitors
Table 151. Asymchem Major Business
Table 152. Asymchem Viral Vector CDMO Services Product and Solutions
Table 153. Asymchem Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 154. Asymchem Recent Developments and Future Plans
Table 155. Exthera Company Information, Head Office, and Major Competitors
Table 156. Exthera Major Business
Table 157. Exthera Viral Vector CDMO Services Product and Solutions
Table 158. Exthera Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 159. Exthera Recent Developments and Future Plans
Table 160. Flash Therapeutics Company Information, Head Office, and Major Competitors
Table 161. Flash Therapeutics Major Business
Table 162. Flash Therapeutics Viral Vector CDMO Services Product and Solutions
Table 163. Flash Therapeutics Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 164. Flash Therapeutics Recent Developments and Future Plans
Table 165. VIVEBiotech Company Information, Head Office, and Major Competitors
Table 166. VIVEBiotech Major Business
Table 167. VIVEBiotech Viral Vector CDMO Services Product and Solutions
Table 168. VIVEBiotech Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 169. VIVEBiotech Recent Developments and Future Plans
Table 170. FinVector Company Information, Head Office, and Major Competitors
Table 171. FinVector Major Business
Table 172. FinVector Viral Vector CDMO Services Product and Solutions
Table 173. FinVector Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 174. FinVector Recent Developments and Future Plans
Table 175. uBriGene Company Information, Head Office, and Major Competitors
Table 176. uBriGene Major Business
Table 177. uBriGene Viral Vector CDMO Services Product and Solutions
Table 178. uBriGene Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 179. uBriGene Recent Developments and Future Plans
Table 180. Eurogentec Company Information, Head Office, and Major Competitors
Table 181. Eurogentec Major Business
Table 182. Eurogentec Viral Vector CDMO Services Product and Solutions
Table 183. Eurogentec Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 184. Eurogentec Recent Developments and Future Plans
Table 185. VGXI Company Information, Head Office, and Major Competitors
Table 186. VGXI Major Business
Table 187. VGXI Viral Vector CDMO Services Product and Solutions
Table 188. VGXI Viral Vector CDMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 189. VGXI Recent Developments and Future Plans
Table 190. Global Viral Vector CDMO Services Revenue (USD Million) by Players (2018-2023)
Table 191. Global Viral Vector CDMO Services Revenue Share by Players (2018-2023)
Table 192. Breakdown of Viral Vector CDMO Services by Company Type (Tier 1, Tier 2, and Tier 3)
Table 193. Market Position of Players in Viral Vector CDMO Services, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 194. Head Office of Key Viral Vector CDMO Services Players
Table 195. Viral Vector CDMO Services Market: Company Product Type Footprint
Table 196. Viral Vector CDMO Services Market: Company Product Application Footprint
Table 197. Viral Vector CDMO Services New Market Entrants and Barriers to Market Entry
Table 198. Viral Vector CDMO Services Mergers, Acquisition, Agreements, and Collaborations
Table 199. Global Viral Vector CDMO Services Consumption Value (USD Million) by Type (2018-2023)
Table 200. Global Viral Vector CDMO Services Consumption Value Share by Type (2018-2023)
Table 201. Global Viral Vector CDMO Services Consumption Value Forecast by Type (2024-2029)
Table 202. Global Viral Vector CDMO Services Consumption Value by Application (2018-2023)
Table 203. Global Viral Vector CDMO Services Consumption Value Forecast by Application (2024-2029)
Table 204. North America Viral Vector CDMO Services Consumption Value by Type (2018-2023) & (USD Million)
Table 205. North America Viral Vector CDMO Services Consumption Value by Type (2024-2029) & (USD Million)
Table 206. North America Viral Vector CDMO Services Consumption Value by Application (2018-2023) & (USD Million)
Table 207. North America Viral Vector CDMO Services Consumption Value by Application (2024-2029) & (USD Million)
Table 208. North America Viral Vector CDMO Services Consumption Value by Country (2018-2023) & (USD Million)
Table 209. North America Viral Vector CDMO Services Consumption Value by Country (2024-2029) & (USD Million)
Table 210. Europe Viral Vector CDMO Services Consumption Value by Type (2018-2023) & (USD Million)
Table 211. Europe Viral Vector CDMO Services Consumption Value by Type (2024-2029) & (USD Million)
Table 212. Europe Viral Vector CDMO Services Consumption Value by Application (2018-2023) & (USD Million)
Table 213. Europe Viral Vector CDMO Services Consumption Value by Application (2024-2029) & (USD Million)
Table 214. Europe Viral Vector CDMO Services Consumption Value by Country (2018-2023) & (USD Million)
Table 215. Europe Viral Vector CDMO Services Consumption Value by Country (2024-2029) & (USD Million)
Table 216. Asia-Pacific Viral Vector CDMO Services Consumption Value by Type (2018-2023) & (USD Million)
Table 217. Asia-Pacific Viral Vector CDMO Services Consumption Value by Type (2024-2029) & (USD Million)
Table 218. Asia-Pacific Viral Vector CDMO Services Consumption Value by Application (2018-2023) & (USD Million)
Table 219. Asia-Pacific Viral Vector CDMO Services Consumption Value by Application (2024-2029) & (USD Million)
Table 220. Asia-Pacific Viral Vector CDMO Services Consumption Value by Region (2018-2023) & (USD Million)
Table 221. Asia-Pacific Viral Vector CDMO Services Consumption Value by Region (2024-2029) & (USD Million)
Table 222. South America Viral Vector CDMO Services Consumption Value by Type (2018-2023) & (USD Million)
Table 223. South America Viral Vector CDMO Services Consumption Value by Type (2024-2029) & (USD Million)
Table 224. South America Viral Vector CDMO Services Consumption Value by Application (2018-2023) & (USD Million)
Table 225. South America Viral Vector CDMO Services Consumption Value by Application (2024-2029) & (USD Million)
Table 226. South America Viral Vector CDMO Services Consumption Value by Country (2018-2023) & (USD Million)
Table 227. South America Viral Vector CDMO Services Consumption Value by Country (2024-2029) & (USD Million)
Table 228. Middle East & Africa Viral Vector CDMO Services Consumption Value by Type (2018-2023) & (USD Million)
Table 229. Middle East & Africa Viral Vector CDMO Services Consumption Value by Type (2024-2029) & (USD Million)
Table 230. Middle East & Africa Viral Vector CDMO Services Consumption Value by Application (2018-2023) & (USD Million)
Table 231. Middle East & Africa Viral Vector CDMO Services Consumption Value by Application (2024-2029) & (USD Million)
Table 232. Middle East & Africa Viral Vector CDMO Services Consumption Value by Country (2018-2023) & (USD Million)
Table 233. Middle East & Africa Viral Vector CDMO Services Consumption Value by Country (2024-2029) & (USD Million)
Table 234. Viral Vector CDMO Services Raw Material
Table 235. Key Suppliers of Viral Vector CDMO Services Raw Materials
LIST OF FIGURE
s
Figure 1. Viral Vector CDMO Services Picture
Figure 2. Global Viral Vector CDMO Services Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Viral Vector CDMO Services Consumption Value Market Share by Type in 2022
Figure 4. AAV
Figure 5. Lentivirus
Figure 6. Adenovirus
Figure 7. HSV
Figure 8. Others
Figure 9. Global Viral Vector CDMO Services Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 10. Viral Vector CDMO Services Consumption Value Market Share by Application in 2022
Figure 11. Vaccine Development Picture
Figure 12. Gene Therapy Picture
Figure 13. Academic Scientific Research Institution Picture
Figure 14. Others Picture
Figure 15. Global Viral Vector CDMO Services Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Viral Vector CDMO Services Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Market Viral Vector CDMO Services Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 18. Global Viral Vector CDMO Services Consumption Value Market Share by Region (2018-2029)
Figure 19. Global Viral Vector CDMO Services Consumption Value Market Share by Region in 2022
Figure 20. North America Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 21. Europe Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 22. Asia-Pacific Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 23. South America Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 24. Middle East and Africa Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 25. Global Viral Vector CDMO Services Revenue Share by Players in 2022
Figure 26. Viral Vector CDMO Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 27. Global Top 3 Players Viral Vector CDMO Services Market Share in 2022
Figure 28. Global Top 6 Players Viral Vector CDMO Services Market Share in 2022
Figure 29. Global Viral Vector CDMO Services Consumption Value Share by Type (2018-2023)
Figure 30. Global Viral Vector CDMO Services Market Share Forecast by Type (2024-2029)
Figure 31. Global Viral Vector CDMO Services Consumption Value Share by Application (2018-2023)
Figure 32. Global Viral Vector CDMO Services Market Share Forecast by Application (2024-2029)
Figure 33. North America Viral Vector CDMO Services Consumption Value Market Share by Type (2018-2029)
Figure 34. North America Viral Vector CDMO Services Consumption Value Market Share by Application (2018-2029)
Figure 35. North America Viral Vector CDMO Services Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 37. Canada Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 38. Mexico Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 39. Europe Viral Vector CDMO Services Consumption Value Market Share by Type (2018-2029)
Figure 40. Europe Viral Vector CDMO Services Consumption Value Market Share by Application (2018-2029)
Figure 41. Europe Viral Vector CDMO Services Consumption Value Market Share by Country (2018-2029)
Figure 42. Germany Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 43. France Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 44. United Kingdom Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 45. Russia Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 46. Italy Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 47. Asia-Pacific Viral Vector CDMO Services Consumption Value Market Share by Type (2018-2029)
Figure 48. Asia-Pacific Viral Vector CDMO Services Consumption Value Market Share by Application (2018-2029)
Figure 49. Asia-Pacific Viral Vector CDMO Services Consumption Value Market Share by Region (2018-2029)
Figure 50. China Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 51. Japan Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 52. South Korea Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 53. India Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 54. Southeast Asia Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 55. Australia Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 56. South America Viral Vector CDMO Services Consumption Value Market Share by Type (2018-2029)
Figure 57. South America Viral Vector CDMO Services Consumption Value Market Share by Application (2018-2029)
Figure 58. South America Viral Vector CDMO Services Consumption Value Market Share by Country (2018-2029)
Figure 59. Brazil Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 60. Argentina Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 61. Middle East and Africa Viral Vector CDMO Services Consumption Value Market Share by Type (2018-2029)
Figure 62. Middle East and Africa Viral Vector CDMO Services Consumption Value Market Share by Application (2018-2029)
Figure 63. Middle East and Africa Viral Vector CDMO Services Consumption Value Market Share by Country (2018-2029)
Figure 64. Turkey Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 65. Saudi Arabia Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 66. UAE Viral Vector CDMO Services Consumption Value (2018-2029) & (USD Million)
Figure 67. Viral Vector CDMO Services Market Drivers
Figure 68. Viral Vector CDMO Services Market Restraints
Figure 69. Viral Vector CDMO Services Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Manufacturing Cost Structure Analysis of Viral Vector CDMO Services in 2022
Figure 72. Manufacturing Process Analysis of Viral Vector CDMO Services
Figure 73. Viral Vector CDMO Services Industrial Chain
Figure 74. Methodology
Figure 75. Research Process and Data Source
